Back to search results

SHARE Adaptation Intervention for African-American Families for Mild to Moderate Dementia

This study is testing an adapted version of the SHARE program, called the SHARE Adaptation Intervention, for African-American families dealing with mild or moderate dementia. The goal is to make the SHARE program more helpful and culturally relevant for these families. If you join, you would either receive five to six counseling sessions with a SHARE Counselor, or a single educational session with printed resources. The study wants to see how well people attend the sessions, how long the sessions are, and if people stay in the study. You can join if you are an African American caregiver and care-recipient (the person with dementia) where the care-recipient lives at home and has early-stage memory impairment. The study is currently in an unclear status regarding recruitment and plans to enroll 120 participants.

Study design
This is an interventional study comparing two behavioral interventions. It aims to enroll 120 African American care dyads.
What's involved
Participants in the intervention group will have five to six 60-90 minute counseling sessions. The control group will have one educational session.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for attendance and session length within 10 weeks of baseline, and for attrition within 12 weeks of baseline.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07208162

SHARE Adaptation Intervention for African-American Families

Recruiting
NAAges 18+InterventionalTreatment
Benjamin Rose Institute on Aging
~120 participants
Updated 2025-10-06 on ClinicalTrials.gov
What's tested:5+1 Adapted, early-stage dyadic care planning interventionCounseling session and printed resources

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Session length
Measured over After each session; within 10 weeks of baseline.
+9 more outcomes measured

Conditions

Mild Dementia
Moderate Dementia

Explore related trials

Dementia

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Silvia Orsulic-Jeras · PRINCIPAL_INVESTIGATOR · Benjamin Rose Institute on Aging

Who to contact

Silvia Orsulic-Jeras
[email protected]
2163731625
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

African American dyads (both the caregivers and the care-recipient, an individual with an early-stage memory impairing condition (e.g., Alzheimer's disease, vascular dementia, cognitive impairment, etc.)
Care-recipient lives at home.
The caregiver (CG) and/or the person with dementia (PWD), or symptoms of memory loss must identify as African American.
PWD must be at least 50 years old and CGs 18 or older,
Ability to speak and read English,
Experiencing signs and symptoms of mild to moderate dementia through family caregiver report on the Dementia Severity Rating Scale and meeting the National Institute on Aging and the Alzheimer's Association clinical criteria for probable AD.

Exclusion

A mental health condition (e.g., schizophrenia, bipolar disorder, major depression)
A traumatic brain injury
Intellectual or developmental disability
Individuals experiencing extreme difficulty adjusting and coping to the diagnosis • Individuals living in an institutional setting

What this trial measures

  • Session lengthAfter each session; within 10 weeks of baseline.

    SHARE counselors will report length of each session, and we will determine the number of sessions conducted were within 60-90 minutes - the prescribed treatment protocol.

  • AttendanceAfter each session; within 10 weeks of baseline.

    SHARE counselors will report the number of sessions attended out of 6 treatment sessions offered.

  • AttritionFollow up (T2); within 12 weeks of baseline.

    We will assess the number of caregivers and PLWD retained at follow-up

  • Satisfaction with sessionAfter each session; within 10 weeks of baseline.

    Caregivers and PLWD will be asked about their satisfaction with SHARE regarding the: 1) experience; 2) counselor; 3) materials; 4) sessions; 5) postintervention relationship functioning.

  • Treatment processFollow up (T2); within 12-weeks of baseline.

    Caregivers and PLWD will be asked to agree or disagree with statements about SHARE Counselor, understanding of choices, knowledge of dementia, connection to care partner.

  • Overall satisfactionFollow up (T2); within 12 weeks of baseline.

    Caregivers and PLWD will be asked to rate their satisfaction with care values and preferences discussions, spacing between sessions, importance of knowledge gained, etc.

  • UtilityFollow up (T2); within 12 weeks of baseline.

    Caregivers and PLWD will be asked to rate the usefulness of materials and information shared, skill of counselor, commitment to care plan.

  • Feasibility of SHAREFollow up (T2); within 12 weeks of baseline.

    Caregivers and PLWD will be asked about the appropriateness of time spent in session and number of sessions.

  • AcceptabilityFollow up (T2); within 12 weeks of baseline.

    Caregivers and PLWD will be asked about the main benefits and drawbacks of SHARE.

  • GoalsFollow up (T2); within 12 weeks of baseline.

    Caregivers and PLWD will be asked to indicate their goals of participating in SHARE, such as: Dementia education, communication skills, knowledge of resources, building a network of support, etc.